USPTO serial 79357872
C CANCER RESEARCH HORIZONS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 2, 2024
- Examiner
- RIEPEL, CHRISTINA MAXINE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with C CANCER RESEARCH HORIZONS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in the pharmaceutical research, development or manufacturing industry; chemical preparations for use in the manufacture of pharmaceuticals; cultures of cell media for scientific and research use; media for cell culture for laboratory use in the biotechnological industry; media for cell culture for use in non-medical research laboratories; media for cell culture for use in medical research laboratories | ACTIVE | — |
| 005 | Pharmaceutical products for the diagnosis, prevention or treatment of cancer; cultures of cell media for medical and veterinary use; living cells for medical or veterinary use | ACTIVE | — |
| 010 | Medical apparatus and instruments, namely for the diagnosis, prevention or treatment of cancer; surgical apparatus and instruments; diagnostic apparatus for medical purposes for the diagnosis or prevention of cancer | ACTIVE | — |
| 035 | promotion and advertising of products and services for others for the treatment of cancer; marketing of products and services for others for the treatment of cancer; business project management; business intermediary services in the nature of connecting buyers and sellers for the sale and purchase of goods and services for the treatment of cancer; business information services; providing an on-line commercial information directory for products and services for the treatment of cancer; providing advertising information featuring goods and services of others for the treatment of cancer via an on-line searchable database; business advisory services relating to the commercialisation of products and services for the treatment of cancer | ACTIVE | — |
| 036 | Charitable fundraising; Charitable collections in the nature of charitable fundraising; Organisation of charitable collections in the nature of charitable fundraising; charitable fundraising services by means of organisation of fundraising activities and events to support cancer research; providing financial grants for the purpose of research, diagnosis, treatment and prevention of cancer | ACTIVE | — |
| 041 | Organisation of community sporting and cultural events; arranging and conducting of conferences and seminars in the field of cancer prevention, diagnosis and treatment; education services, namely courses, seminars, workshops and conferences featuring subject matter related to alleviation, diagnosis, prevention and treatment of cancer; the publication of books, texts and magazines; developing and conducting educational programs in the fields of health, diet, nutrition, cancer and cancer prevention | ACTIVE | — |
| 042 | Scientific and medical research services; providing medical and scientific research information relating to alleviation, diagnosis, prevention and treatment of cancer; Conducting research in the fields of health, diet, nutrition, cancer and cancer prevention; conducting clinical trials for others in the field of oncology; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; biomedical research services; laboratory research services relating to cancer and diagnosis, prevention or treatment thereof; medical research in the field of oncology; scientific advisory services relating to chemical reagents; scientific advisory services relating to biological reagents; Clinical or medical laboratory services relating to the production of monoclonal antibodies; laboratory research in the field of gene expression | ACTIVE | — |
| 045 | Licensing of intellectual property; licensing of intellectual property for use in the treatment of cancer | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Cancer Research Technology Limited
- Other trademarks owned by Cancer Research Technology Limited
- Other trademarks owned by Cancer Research Technology Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 036
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 045
- Similar marks named C CANCER RESEARCH HORIZONS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 18, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 30, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 9, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 9, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 2, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 2, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 2, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 17, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 17, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 17, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 27, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 27, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Sep 27, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 8, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 8, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 8, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 8, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 8, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 29, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 28, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 28, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 4, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 10, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 10, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 26, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 25, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 19, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 23, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 19, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 17, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |